OPPM
ANAB icon

Opus Point Partners Management’s AnaptysBio ANAB Stock Holding History

Opus Point Partners Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,116
Closed -$345K – 57
2019
Q2 		$345K Hold
6,116
– – 0.51% 46
2019
Q1 		$447K Buy
+6,116
New +$422K 0.61% 39

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Opus Point Partners Management's ANAB Position: Q3 2019 in Review

Opus Point Partners Management sold out of AnaptysBio (ANAB) in Q3 2019, closing a stake of 6,116 shares — an estimated $345K sold.

Opus Point Partners Management first reported a position in ANAB in Q1 2019 and held it in 2 quarters. The position peaked at $447K in Q1 2019. 119 funds tracked by Wall St. Rank hold ANAB as of Q3 2019.

  • Opus Point Partners Management reported no remaining AnaptysBio position as of Q3 2019 after selling out during the quarter.
  • Opus Point Partners Management sold 6,116 AnaptysBio shares in Q3 2019, an estimated $345K.
  • Opus Point Partners Management first reported a position in AnaptysBio in Q1 2019 and held it in 2 quarters.
  • Opus Point Partners Management's AnaptysBio position peaked at $447K in Q1 2019.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.